Terrible unprofessional Senior Management - Manager Vyriad Employee Review

2.0
3 Apr 2023
Recommend
CEO approval
Business outlook

Pros

The technology is amazing and has potential to change many lives

Cons

Poorly run Sr. Management, company relies heavily on MAYO Clinic for everything. Management is terrible, they never listen to employees and have little to no understanding of business sense. They often hire very skilled individuals and than treat them as if they are in the acidemia world still. Almost everyone hired is lied too, told the company will be public within a few years, treated terrible and are stuck due to the lack of similar industries in the area. There is no diversity or inclusion with little understanding of real world working class individuals. Nepotism is throughout the company in different roles and places with the sister company Imanis Life Sciences as well.

Explore other reviews about Vyriad

5.0
8 Jun 2026
Recommend
CEO approval
Business outlook

Pros

great sciences, friendly culture, plenty of opportunity, good benefit and bonus

Cons

small city but growing, not close to any bio-hub mega cities

1.0
24 Jun 2026
Recommend
CEO approval
Business outlook

Pros

The interviews and the promises made at the time of recruitment gives the impression of a promising and innovative research environment.

Cons

The company’s perspective on science appears limited, likely a reflection of operating in a small, insular environment with limited exposure to broader scientific communities and standards. Leadership culture is challenging — there is little room for independent thinking, and a tendency toward favoritism and nepotism is evident at the highest levels of management. The Chief Scientific Officer in particular sets a troubling tone for the toxic work culture. Her management style includes publicly demeaning and belittling employees she doesn’t like or feels threatened by. This behavior from someone in such a senior role is deeply damaging to employee morale and goes unchecked. Despite considerable time in operation, the company has little in terms of tangible products or outcomes to demonstrate. Compensation is below market for the level of expertise they recruit. The gap between what is promised during hiring and the day-to-day reality can be disappointing. Employees do not feel genuinely valued, and there is minimal investment in professional development or long-term career growth. Companies in the biotech space that make ambitious claims without accountability would benefit from greater external oversight and transparency. Prospective candidates are encouraged to ask hard questions during the interview process and look beyond the initial enthusiasm before committing.

See reviews by: Helpful|Rating|Date|All